Sign in to view content

Port Delivery System With Ranibizumab: Key Outcomes From the Ladder Phase 2 Trial That Supported Archway Phase 3 Study Design

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2019

Arshad M. Khanani, MD

AMD Neovascular Part II Symposium

Related

FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Ivan J. Suner, MD, MBA
Annual Meeting Talks
2019
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes From the Randomized RECOVERY Trial
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2019
Intravitreal Anti-VEGF Injections for Exudative Retinal Arterial Macroaneurysms: Results of an International Multicenter Study
J. Fernando Arevalo, MD, PhD, FACS, FASRS
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more